| ²é¿´: 1809 | »Ø¸´: 29 | ||
| ¡¾½±Àø¡¿ ±¾Ìû±»ÆÀ¼Û20´Î£¬×÷Õßluhaitao84Ôö¼Ó½ð±Ò 16.5 ¸ö | ||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | ||
luhaitao84ÖÁ×ðľ³æ (ÖøÃûдÊÖ)
|
[×ÊÔ´]
RNAi¼¼ÊõÊÖ²áºÍÃÀ¹úÉúÎïÐÅϢѧÅàÑø¼Æ»®£¨ÒÑÎÞÖØ¸´ËÑË÷£©
|
|
|
RNAi¼¼ÊõÊÖ²áºÍÃÀ¹úÉúÎïÐÅϢѧÅàÑø¼Æ»® ºóÃæ·¢²¼¹ØÓÚRNA¼¼ÊõµÄ¶«¶« |
» ²ÂÄãϲ»¶
297£¬¹¤¿Æµ÷¼Á?
ÒѾÓÐ4È˻ظ´
¿ÒÇëÓÐѧУÊÕÁô
ÒѾÓÐ7È˻ظ´
291Çóµ÷¼Á
ÒѾÓÐ9È˻ظ´
300Çóµ÷¼Á
ÒѾÓÐ11È˻ظ´
22ר˶Çóµ÷¼Á
ÒѾÓÐ12È˻ظ´
²ÄÁÏÏà¹Ø×¨Òµ344Çóµ÷¼ÁË«·Ç¹¤¿ÆÑ§Ð£»ò¿ÎÌâ×é
ÒѾÓÐ25È˻ظ´
¼±Ðèµ÷¼Á
ÒѾÓÐ7È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
Ò»Ö¾Ô¸»ªÖÐũҵ071010£¬320Çóµ÷¼Á
ÒѾÓÐ16È˻ظ´
304Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
luhaitao84
ÖÁ×ðľ³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 7 (Ó×¶ùÔ°)
- ¹ó±ö: 1.412
- ½ð±Ò: 10417.6
- Ìû×Ó: 1698
- ÔÚÏß: 75.3Сʱ
- ³æºÅ: 580938
|
1.ÔÚÉè¼ÆRNAiʵÑéʱ£¬¿ÉÒÔÏÈÔÚÒÔÏÂÍøÕ¾½øÐÐÄ¿±êÐòÁеÄɸѡ£º http://www.ambion.com/techlib/misc/siRNA_finder.html http://katahdin.cshl.org:9331/RNAi/ http://www.ic.sunysb.edu/Stu/shilin/rnai.html 2.RNAiÄ¿±êÐòÁеÄѡȡÔÔò£º £¨1£©siRNAs with lower G/C content (35-55%) are more active than those with G/C content higher than 55%£» £¨2£©Beginning with the AUG start codon of your transcript, scan downstream for AA dinucleotide sequences. Record the occurrence of each AA and the 3' adjacent 19 nucleotides as potential siRNA target sites. Tuschl, et al. recommend against designing siRNA to the 5' and 3' untranslated regions (UTRs) and regions near the start codon (within 75 bases) as these may be richer in regulatory protein binding sites. UTR-binding proteins and/or translation initiation complexes may interfere with binding of the siRNP endonuclease complex. £¨3£©Compare the potential target sites to the appropriate genome database (human, mouse, rat, etc.) and eliminate from consideration any target sequences with significant homology to other coding sequences. 3.siRNAµÄºÏ³É£º (1)IN VITRO: siRNAs generated in vitro by transcription with T7 DNA polymerase; (2)IN VIVO: Short hairpin RNAs that are transcribed in vivo from vectors containing the human U6 promoter. 4.ĿǰÒÑ֤ʵµÄsiRNA¿ÉÒÔÔÚÏÂÃæµÄÍøÒ³ÕÒµ½£º http://www.dharmacon.com/4DCGI/W ... 7/4DWPG_11054394851 |
2Â¥2009-04-26 00:35:40
luhaitao84
ÖÁ×ðľ³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 7 (Ó×¶ùÔ°)
- ¹ó±ö: 1.412
- ½ð±Ò: 10417.6
- Ìû×Ó: 1698
- ÔÚÏß: 75.3Сʱ
- ³æºÅ: 580938
|
RNAi×ÊÔ´£º http://immuneweb.xxmc.edu.cn/RNAi.htm http://www.orbigen.com/RNAi_Orbigen.html http://www.imb-jena.de/RNA.html ÉÌÒµ»¯µÄRNAiÔØÌ壺 http://www.invivogen.com/siRNA/psiRNA.htm http://www.ambion.com/catalog/CatNum.php?7209 http://www.imgenex.com/products_genesuppressor.html http://www.oligoengine.com/Home/mid_prodPSUPER.html ¹¦ÄÜ»ùÒò×é¡¢µ°°×ÖÊ×é×ÊÔ´£¨Êý¾Ý¿â£¬·ÖÎöÈí¼þµÈ £© BioSino Navigator http://www.biosino.org/pages/gateways.htm ¹¦ÄÜ»ùÒò×é×ÊÔ´£ºµ°°×ÖÊ×é °üÀ¨³£ÓÃ×ÊÔ´£¬µ°°×-µ°°×Ï໥×÷ÓÃÊý¾Ý¿â£¬µ°°×ÖʼÒ×åÊý¾Ý¿â£¬·ÖÎöÈí¼þµÈ http://www.biosino.org/bioinformatics/010929-6.htm Metabolic Pathways 14 Cell Cycle 6 Signal Transduction 12 ExPASy Biochemical Pathways Digitized version of wall charts courtesy Boehringer Mannheim et al,divided into Metabolic Pathways and Cellular and Molecular Processes,maintained by the Swiss Institute of Bioinformatics,Geneva,Switzerland.Diagram of steps in Krebs tricarb http://www.maninnet.com/phod.php ... Metabolic_Pathways/ Chemical Network -- Chemical Industry Directory All Categories Just in this category Biochemicals About 78records found Showing 41 60of 78 3 A company operating in the forefront of genetic engineering as well as DNA,RNA and protein research.This is the ExPASy Expert Protein Analysis System proteomics server of t http://www.chemnet.com/dir/Europe/Pharmaceuticals,_biochemicals_and_intermediates/Biochemicals/index3.html µ°°×ÖÊ×éѧ £¨Proteomics£© 90Äê´ú³õÆÚ¿ªÊ¼ÊµÊ©µÄÈËÀà»ùÒò×鼯»®£¬ÔÚ¾¹ý¸÷¹ú¿ÆÑ§¼Ò½ü10ÄêµÄŬÁ¦Ï£¬ÒѾȡµÃÁ˾޴óµÄ³É¾Í¡£²»½öÍê³ÉÁËÊ®ÓàÖÖģʽÉúÎ´Ó´ó³¦¸Ë¾ú Äð¾Æ½Íĸµ½Ï߳棩»ùÒò×éÈ«ÐòÁеIJⶨ¹¤×÷£¬»¹ÓÐÍûÔÚ2003ÄêÌáǰÍê³ÉÈËÀàËùÓлùÒòµÄÈ«ÐòÁвⶨ¡£ÄÇô£¬ÖªµÀÁËÈËÀàµÄÈ«²¿ÒÅ´«ÃÜÂë¼´»ùÒò×éÐòÁУ¬¾Í¿ÉÒÔÈÎÒâ¿ØÖÆÈ˵ÄÉúÀϲ¡ËÀÂð£¿Æäʵ²¢²»ÊÇÕâô¼òµ¥¡£»ùÒò×éѧ£¨genomics£©ËäÈ»ÔÚ ... http://www.newlifebp.org.cn/shidian/zhuanti/proteomics.htm ÍøÉϵ°°×ÖÊ×éѧ×ÊÔ´ ÓÉÓÚµ°°×ÖÊ×éѧÑо¿ÒÀÀµÉúÎïÐÅϢѧºÍÍøÂç¼¼Êõ£¬internet ÉÏÓйص°°×ÖÊ×éÑо¿µÄ¼¼ÊõÖ§³ÖÒÔ¼°µ°°×ÖÊÊý¾Ý·ÖÎöµÄר¼Òϵͳ¡¢Êý¾Ý¿âµÈרÃÅÍøÕ¾ºÜ¶à¡£ ¡¤ www.proteomeworks.bio-rad.com µ°°×ÖÊ×éÑо¿¼¼Êõ¡¢ÐÅÏ¢µÈ¡£ ¡¤ www.proteinpathways.com ´ÓÐÂÒ©¿ª·¢½Ç¶È£¬·¢ÏÖе°°×¼°ÐÂ×÷Óᣠ¡¤ www.proteome.med.umich.edu ¿ÉÒÔÕÒµ½µ°°×ÖÊ×éÑо¿Ïà¹ØÆóÒµ¡¢¸÷ÖÖÒÇÆ÷À´Ô´¡¢ÐÂÎŵȡ£ ¡¤ www.proteome.co.uk ¸÷ÖÖµ°°×ÖÊ×éÑо¿Ïà¹ØÐÅÏ¢ ¡¤ www.micromass.co.uk ½éÉܵ°°×Öʼø¶¨µÄÏȽøÒÇÆ÷ ¡¤ http://www.expasy.ch µ°°×Öʼø¶¨×¨¼Òϵͳ£¬Swiss Institute of Bioinformatics ¡¤ http://expasy.proteome.org.au µ°°×Öʼø¶¨×¨¼Òϵͳ£¬Australian Proteome Analysis Facility ¡¤ http://expasy.cbr.nrc.ca µ°°×Öʼø¶¨×¨¼Òϵͳ£¬Canadian Bioinformatics Resourse ¡¤ Desktop Sequence Analysis Software ÕâÊǹúÍâרÀ¸×÷¼ÒдµÄÎÄÕ¡£¶ÔÐòÁзÖÎö¹¤¾ß×öÁËÏêϸµÄ½éÉÜ¡£ÎÄÕÂÎıÊÁ÷³©£¬²ã´ÎÇåÎú£¬Ëù½éÉܵÄÈí¼þ²»½ö°üÀ¨Ñ§ÊõÉϳ£ÓõÄÃâ·ÑÈí¼þ£¬Ò²°üÀ¨ÄÇЩ¹¦ÄÜÇ¿´óµÄÉÌÒµÈí¼þ¡£ÎÄÕ¶Ը÷ÖÖÈí¼þ½øÐÐÁË·ÖÃűðÀàµÄ½éÉÜ£¬¶ÔÈí¼þµÄÌØÐÔÒ²ÓкܺõIJûÊö¡£ÎÞÂÛ¶Ô³õѧÕß»¹ÊÇרҵÈËÔ±¶¼ÊǺܺõIJο¼×ÊÁÏ http://www.biosino.org/bioinformatics/011205-3.htm Database Mining in the Human Genome Initiative http://www.biosino.org/bioinformatics/0902-6.htm Biopath£ºÉú»¯ÍøÂçµÄ¿ÉÊÓ»¯Õ¹Ê¾ ÖÚ¶àµÄÉú»¯·´Ó¦¹¹³ÉÁËÅÓ´ó¶ø¸´ÔÓµÄÍøÂ磬ÕýÊÇÕâÑùÒ»¸öÌåϵÐÐʹ×ÅÖÖÖÖÉúÀí¹¦ÄÜ¡£È«ÃæµÄ¿ÉÊÓ»¯µÄÕ¹Ê¾ÍøÂçÖи÷ÖÖ×ÓÍøºÍ·¾¶¿ÉÒÔ°ïÖúÉú»¯Ñ§¼ÒÃÅÀí½â¸÷ÖÖ·´Ó¦µ×ÎïÖ®¼äµÄÏ໥¹ØÏµ£¬ÓÐÖúÓÚÑо¿µÄ¿ªÕ¹¡£´«Í³ÉÏÀ´Ëµ£¬ÕâÐ©ÍøÂçͼÊÇÈ˹¤ÊÖ»æµÄ¡£µ«ÊÇ£¬Ëæ×ŶÔÉú»¯ÍøÂç֪ʶµÄÖð²½»ýÀÛºÍÉîÈëÁ˽⣬×Ô¶¯»¯µÄÉú³ÉºÍ¿ÉÊÓ»¯¾Í±äµÄºÜÓбØÒªÁË¡£BioPathÊÇÒ»ÖÖ·ûºÏÉÏÊöÒªÇóµÄÈí¼þϵͳ¡£BioPathÒªÒ»¸öÌØ±ðµÄÊý¾Ý¿â£¬ÆäÖаüº¬Á˸÷ÖÖ·´Ó¦¡¢¸÷Öֵİ´µÈ¼¶µÄ·ÖÀàÒÔ¼°·´Ó¦ÍøÂç¡£Biopath¿ÉÒÔ´ÓÊý¾Ý¿âÖÐ×Ô¶¯Éú³ÉÍøÂçºÍËüÃǵĸßÖÊÁ¿µÄ¿ÉÊÓ»¯±íʾ¡£ÏÂÃæÕâÆªÎÄÕ¸ÃÈí¼þµÄËã·¨¡¢Ê¹Ó÷½·¨ºÍ¿ÉÄܵÄÓÃ;¡£ ¡¡http://www.biosino.org/bioinformatics/20020417-1.htm .µ°°×ÖÊÊý¾Ý¿â 1.PIRºÍPSD PIR¹ú¼Êµ°°×ÖÊÐòÁÐÊý¾Ý¿â PSD ÊÇÓɵ°°×ÖÊÐÅÏ¢×ÊÔ´ PIR ĽÄáºÚµ°°×ÖÊÐòÁÐÐÅÏ¢ÖÐÐÄ MIPS ºÍÈÕ±¾¹ú¼Êµ°°×ÖÊÐòÁÐÊý¾Ý¿â JIPID ¹²Í¬Î¬»¤µÄ¹ú¼ÊÉÏ×î´óµÄ¹«¹²µ°°×ÖÊÐòÁÐÊý¾Ý¿â¡£ÕâÊÇÒ»¸öÈ«ÃæµÄ ¾¹ý×¢Ê굀 ·ÇÈßÓàµÄµ°°×ÖÊÐòÁÐÊý¾Ý¿â£¬°üº¬³¬¹ý142,000Ìõµ°°×ÖÊÐòÁÐ ÖÁ99Äê9Ô £¬ÆäÖаüÀ¨À´×Ô¼¸Ê®¸öÍêÕû»ùÒò×éµÄµ°°×ÖÊÐòÁС£ËùÓÐÐòÁÐÊý¾Ý¶¼¾¹ýÕûÀí£¬³¬¹ý99 µÄÐòÁÐÒѰ´µ°°×ÖÊ http://www.bioisland.com.cn/ibidb/html/prodb.htm Testing and laboratory services http://www.chemnet.com/dir/Indus ... rvices/index18.html Chemical Network -- Chemical Industry Directory http://www.chemnet.com/dir/Regional/Switzerland/index3.html The guide: Step 1 obtaining a sequence of interest If you have a sequence of interest proceed to step 2.Once you obtained your sequence of interest YSI save it in a file using the Save As command of your browser.Search a public version of full Medline for topics of interest US Search for sequences of interest US Search protein and nucleic acid databas http://www.biosino.org/mirror/bi ... .il/gdp/gdlist.html Bioinformatics and XML XMLÒòÆä½«Êý¾ÝÐÅÏ¢±¾ÉíµÄ´æ´¢Óë¹ØÁªÓë±íÏÖÐÎʽÏà·ÖÀ룬ǿ´óµÄ¿ÉÀ©Õ¹ÐÔ£¬±¾Éí²ã´ÎÇåÎúµÄÊ÷ÐÎ½á¹¹ÌØÐÔÒÔ¼°¿çƽ̨ ¿çÓïÑÔµÄÌØÐÔ¶ø³ÉΪÁ¼ºÃÍø¼ÊÓïÑÔ£¬²¢ÔÚ¸÷ÖÖÊý¾ÝºÍ´æÈ¡¹¤×÷ÖдóÏÔÉñͨ¡£ÉúÎïÐÅϢѧµÄ·¢Õ¹Í¬ÑùÒýÈëÁËXML¼¼Êõ¡£ÏÂÃæÕâÆªÎÄÕÂÊÇÒ»¸öרҵÐÔµÄÆÀÂÛ£¬ÎÄÕ·ÖÎöÁËÏÖÔÚXML¼¼ÊõÔÚÉúÎïÐÅϢѧ .. http://www.biosino.org/bioinformatics/011212-2.htm Online Services http://www.maninnet.com/phod.php ... cs/Online_Services/ Proteins http://www.maninnet.com/phod.php ... Structure/Proteins/ |
3Â¥2009-04-26 00:36:43
luhaitao84
ÖÁ×ðľ³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 7 (Ó×¶ùÔ°)
- ¹ó±ö: 1.412
- ½ð±Ò: 10417.6
- Ìû×Ó: 1698
- ÔÚÏß: 75.3Сʱ
- ³æºÅ: 580938
|
ÖøÃûºÍÓÐÌØÉ«µÄÉúÎïÐÅÏ¢Êý¾Ý¿â¡ª¡ª·ÖÀà½éÉÜ ½üÄêÀ´´óÁ¿ÉúÎïѧʵÑéµÄÊý¾Ý»ýÀÛ£¬ÐγÉÁ˵±Ç°ÊýÒ԰ټƵÄÉúÎïÐÅÏ¢Êý¾Ý¿â¡£ËüÃǸ÷×Ô°´Ò»¶¨µÄÄ¿±êÊÕ¼¯ºÍÕûÀíÉúÎïѧʵÑéÊý¾Ý£¬²¢ÌṩÏà¹ØµÄÊý¾Ý²éѯ¡¢Êý¾Ý´¦ÀíµÄ·þÎñ¡£Ëæ×ÅÒòÌØÍøµÄÆÕ¼°£¬ÕâЩÊý¾Ý¿â´ó¶à¿ÉÒÔͨ¹ýÍøÂçÀ´·ÃÎÊ£¬»òÕßͨ¹ýÍøÂçÏÂÔØ¡£ Ò»°ã¶øÑÔ£¬ÕâЩÉúÎïÐÅÏ¢Êý¾Ý¿â¿ÉÒÔ·ÖΪһ¼¶Êý¾Ý¿âºÍ¶þ¼¶Êý¾Ý¿â¡£Ò»¼¶Êý¾Ý¿âµÄÊý¾Ý¶¼Ö±½ÓÀ´Ô´ÓÚʵÑé»ñµÃµÄÔʼÊý¾Ý£¬Ö»¾¹ý¼òµ¥µÄ¹éÀàÕûÀíºÍ×¢ÊÍ£»¶þ¼¶Êý¾Ý¿âÊÇÔÚÒ»¼¶Êý¾Ý¿â¡¢ÊµÑéÊý¾ÝºÍÀíÂÛ·ÖÎöµÄ»ù´¡ÉÏÕë¶ÔÌØ¶¨Ä¿±êÑÜÉú¶øÀ´£¬ÊǶÔÉúÎïѧ֪ʶºÍÐÅÏ¢µÄ½øÒ»²½ÕûÀí¡£¹ú¼ÊÉÏÖøÃûµÄÒ»¼¶ºËËáÊý¾Ý¿âÓÐGenbankÊý¾Ý¿â¡¢EMBLºËËá¿âºÍDDBJ¿âµÈ£»µ°°×ÖÊÐòÁÐÊý¾Ý¿âÓÐSWISS-PROT¡¢PIRµÈ£»µ°°×Öʽṹ¿âÓÐPDBµÈ¡£¹ú¼ÊÉ϶þ¼¶ÉúÎïѧÊý¾Ý¿â·Ç³£¶à£¬ËüÃÇÒòÕë¶Ô²»Í¬µÄÑо¿ÄÚÈݺÍÐèÒª¶ø¸÷¾ßÌØÉ«£¬ÈçÈËÀà»ùÒò×éͼÆ×¿âGDB¡¢×ªÂ¼Òò×ӺͽáºÏλµã¿âTRANSFAC¡¢µ°°×Öʽṹ¼Ò×å·ÖÀà¿âSCOPµÈµÈ¡£ ÏÂÃæ½«Ë³Ðò¼òÒª½éÉÜÒ»Ð©ÖøÃûºÍÓÐÌØÉ«µÄÉúÎïÐÅÏ¢Êý¾Ý¿â¡£ 2.1 »ùÒòºÍ»ùÒò×éÊý¾Ý¿â 1. Genbank Genbank¿â°üº¬ÁËËùÓÐÒÑÖªµÄºËËáÐòÁк͵°°×ÖÊÐòÁУ¬ÒÔ¼°ÓëËüÃÇÏà¹ØµÄÎÄÏ×Öø×÷ºÍÉúÎïѧעÊÍ¡£ËüÊÇÓÉÃÀ¹ú¹úÁ¢ÉúÎï¼¼ÊõÐÅÏ¢ÖÐÐÄ(NCBI)½¨Á¢ºÍά»¤µÄ¡£ËüµÄÊý¾ÝÖ±½ÓÀ´Ô´ÓÚ²âÐò¹¤×÷ÕßÌá½»µÄÐòÁУ»ÓɲâÐòÖÐÐÄÌá½»µÄ´óÁ¿ESTÐòÁÐºÍÆäËü²âÐòÊý¾Ý£»ÒÔ¼°ÓëÆäËüÊý¾Ý»ú¹¹Ð×÷½»»»Êý¾Ý¶øÀ´¡£GenbankÿÌì¶¼»áÓëÅ·ÖÞ·Ö×ÓÉúÎïѧʵÑéÊÒ(EMBL)µÄÊý¾Ý¿â£¬ºÍÈÕ±¾µÄDNAÊý¾Ý¿â(DDBJ)½»»»Êý¾Ý£¬Ê¹ÕâÈý¸öÊý¾Ý¿âµÄÊý¾Ýͬ²½¡£µ½1999Äê8Ô£¬GenbankÖÐÊÕ¼¯µÄÐòÁÐÊýÁ¿´ïµ½460ÍòÌõ£¬34ÒÚ¸ö¼î»ù£¬¶øÇÒÊý¾ÝÔö³¤µÄËÙ¶È»¹ÔÚ²»¶Ï¼Ó¿ì¡£GenbankµÄÊý¾Ý¿ÉÒÔ´ÓNCBIµÄFTP·þÎñÆ÷ÉÏÃâ·ÑÏÂÔØÍêÕûµÄ¿â£¬»òÏÂÔØ»ýÀÛµÄÐÂÊý¾Ý¡£NCBI»¹Ìṩ¹ã·ºµÄÊý¾Ý²éѯ¡¢ÐòÁÐÏàËÆÐÔËÑË÷ÒÔ¼°ÆäËü·ÖÎö·þÎñ£¬Óû§¿ÉÒÔ´ÓNCBIµÄÖ÷Ò³ÉÏÕÒµ½ÕâЩ·þÎñ¡£ Genbank¿âÀïµÄÊý¾Ý°´À´Ô´ÓÚÔ¼55,000¸öÎïÖÖ£¬ÆäÖÐ56%ÊÇÈËÀàµÄ»ùÒò×éÐòÁÐ(ËùÓÐÐòÁÐÖеÄ34%ÊÇÈËÀàµÄESTÐòÁÐ)¡£Ã¿ÌõGenbankÊý¾Ý¼Ç¼°üº¬Á˶ÔÐòÁеļòÒªÃèÊö£¬ËüµÄ¿ÆÑ§ÃüÃû£¬ÎïÖÖ·ÖÀàÃû³Æ£¬²Î¿¼ÎÄÏ×£¬ÐòÁÐÌØÕ÷±í£¬ÒÔ¼°ÐòÁб¾Éí¡£ÐòÁÐÌØÕ÷±íÀï°üº¬¶ÔÐòÁÐÉúÎïÑ§ÌØÕ÷×¢ÊÍÈ磺±àÂëÇø¡¢×ªÂ¼µ¥Ôª¡¢Öظ´ÇøÓò¡¢Í»±äλµã»òÐÞÊÎλµãµÈ¡£ËùÓÐÊý¾Ý¼Ç¼±»»®·ÖÔÚÈô¸É¸öÎļþÀÈçϸ¾úÀà¡¢²¡¶¾Àà¡¢Á鳤Àà¡¢Äö³ÝÀ࣬ÒÔ¼°ESTÊý¾Ý¡¢»ùÒò×é²âÐòÊý¾Ý¡¢´ó¹æÄ£»ùÒò×éÐòÁÐÊý¾ÝµÈ16À࣬ÆäÖÐESTÊý¾ÝµÈÓÖ±»¸÷×Ô·Ö³ÉÈô¸É¸öÎļþ¡£ (1)GenbankÊý¾Ý¼ìË÷ NCBIµÄÊý¾Ý¿â¼ìË÷²éѯϵͳÊÇEntrez¡£EntrezÊÇ»ùÓÚWeb½çÃæµÄ×ÛºÏÉúÎïÐÅÏ¢Êý¾Ý¿â¼ìË÷ϵͳ¡£ÀûÓÃEntrezϵͳ£¬Óû§²»½ö¿ÉÒÔ·½±ãµØ¼ìË÷GenbankµÄºËËáÊý¾Ý£¬»¹¿ÉÒÔ¼ìË÷À´×ÔGenbankºÍÆäËüÊý¾Ý¿âµÄµ°°×ÖÊÐòÁÐÊý¾Ý¡¢»ùÒò×éͼÆ×Êý¾Ý¡¢À´×Ô·Ö×ÓÄ£ÐÍÊý¾Ý¿â(MMDµÄµ°°×ÖÊÈýά½á¹¹Êý¾Ý¡¢ÖÖȺÐòÁÐÊý¾Ý¼¯¡¢ÒÔ¼°ÓÉPubMed»ñµÃMedlineµÄÎÄÏ×Êý¾Ý¡£ EntrezÌṩÁË·½±ãʵÓõļìË÷·þÎñ£¬ËùÓвÙ×÷¶¼¿ÉÒÔÔÚÍøÂçä¯ÀÀÆ÷ÉÏÍê³É¡£Óû§¿ÉÒÔÀûÓÃEntrez½çÃæÉÏÌṩµÄÏÞÖÆÌõ¼þ(Limits)¡¢Ë÷Òý(Index)¡¢¼ìË÷ÀúÊ·(History)ºÍ¼ôÌù°å(Clipboard)µÈ¹¦ÄÜÀ´ÊµÏÖ¸´ÔӵļìË÷²éѯ¹¤×÷¡£¶ÔÓÚ¼ìË÷»ñµÃµÄ¼Ç¼£¬Óû§¿ÉÒÔÑ¡ÔñÐèÒªÏÔʾµÄÊý¾Ý£¬±£´æ²éѯ½á¹û£¬ÉõÖÁÒÔͼÐη½Ê½¹Û¿´¼ìË÷»ñµÃµÄÐòÁС£¸üÏêϸµÄEntrezʹÓÃ˵Ã÷¿ÉÒÔÔÚ¸ÃÖ÷Ò³ÉÏ»ñµÃ¡£ (2)ÏòGenbankÌá½»ÐòÁÐÊý¾Ý ²âÐò¹¤×÷Õß¿ÉÒÔ°Ñ×Ô¼º¹¤×÷ÖлñµÃµÄÐÂÐòÁÐÌá½»¸øNCBI£¬Ìí¼Óµ½GenbankÊý¾Ý¿â¡£Õâ¸öÈÎÎñ¿ÉÒÔÓÉ»ùÓÚWeb½çÃæµÄBankIt»ò¶ÀÁ¢³ÌÐòSequinÀ´Íê³É¡£ BankItÊÇһϵÁÐ±íµ¥£¬°üÀ¨ÁªÂçÐÅÏ¢¡¢·¢²¼ÒªÇó¡¢ÒýÓòο¼ÐÅÏ¢¡¢ÐòÁÐÀ´Ô´ÐÅÏ¢¡¢ÒÔ¼°ÐòÁб¾ÉíµÄÐÅÏ¢µÈ¡£Óû§Ìá½»ÐòÁк󣬻á´Óµç×ÓÓʼþÊÕµ½×Ô¶¯Éú³ÉµÄÊý¾ÝÌõÄ¿£¬GenbankµÄÐÂÐòÁбàºÅ£¬ÒÔ¼°Íê³É×¢ÊͺóµÄÍêÕûµÄÊý¾Ý¼Ç¼¡£Óû§»¹¿ÉÒÔÔÚBankItÒ³ÃæÏÂÐÞ¸ÄÒѾ·¢²¼ÐòÁеÄÐÅÏ¢¡£BankItÊʺÏÓÚ¶ÀÁ¢²âÐò¹¤×÷ÕßÌá½»ÉÙÁ¿ÐòÁУ¬¶ø²»ÊʺϴóÁ¿ÐòÁеÄÌá½»£¬Ò²²»ÊʺÏÌá½»ºÜ³¤µÄÐòÁУ¬ESTÐòÁкÍGSSÐòÁÐÒ²²»Ó¦ÓÃBankItÌá½»¡£BankItʹÓÃ˵Ã÷ºÍ¶ÔÐòÁеÄÒªÇó¿ÉÏê¼ûÆäÖ÷Ò³Ãæ¡£ ´óÁ¿µÄÐòÁÐÌá½»¿ÉÒÔÓÉSequin³ÌÐòÍê³É¡£Sequin³ÌÐòÄÜ·½±ãµÄ±à¼ºÍ´¦Àí¸´ÔÓ×¢ÊÍ£¬²¢°üº¬Ò»ÏµÁÐÄÚ½¨µÄ¼ì²éº¯ÊýÀ´Ìá¸ßÐòÁеÄÖÊÁ¿±£Ö¤¡£Ëü»¹±»Éè¼ÆÓÃÓÚÌá½»À´×Ôϵͳ½ø»¯¡¢ÖÖȺºÍÍ»±äÑо¿µÄÐòÁУ¬¿ÉÒÔ¼ÓÈë±È¶ÔµÄÊý¾Ý¡£Sequin³ýÁËÓÃÓڱ༺ÍÐÞ¸ÄÐòÁÐÊý¾Ý¼Ç¼£¬»¹¿ÉÒÔÓÃÓÚÐòÁеķÖÎö£¬ÈκÎÒÔFASTA»òASN.1¸ñʽÐòÁÐΪÊäÈëÊý¾ÝµÄÐòÁзÖÎö³ÌÐò¶¼¿ÉÒÔÕûºÏµ½Sequin³ÌÐòÏ¡£ÔÚ²»Í¬²Ù×÷ϵͳÏÂÔËÐеÄSequin³ÌÐò¶¼¿ÉÒÔÔÚftp://ncbi.nlm.nih.gov/sequin/ÏÂÕÒµ½£¬SequinµÄʹÓÃ˵Ã÷¿ÉÏê¼ûÆäÍøÒ³¡£ NCBIµÄÍøÖ·ÊÇ£ºhttp://www.ncbi.nlm.nih.gov/¡£ EntrezµÄÍøÖ·ÊÇ£ºhttp://www.ncbi.nlm.nih.gov/entrez/¡£ BankItµÄÍøÖ·ÊÇ£º£ºhttp://www.ncbi.nlm.nih.gov/BankIt¡£ SequinµÄÏà¹ØÍøÖ·ÊÇ£º£ºhttp://www.ncbi.nlm.nih.gov/Sequin/¡£ 2. EMBLºËËáÐòÁÐÊý¾Ý¿â EMBLºËËáÐòÁÐÊý¾Ý¿âÓÉÅ·ÖÞÉúÎïÐÅϢѧÑо¿Ëù(EBI)ά»¤µÄºËËáÐòÁÐÊý¾Ý¹¹³É£¬ÓÉÓÚÓëGenbankºÍDDBJµÄÊý¾ÝºÏ×÷½»»»£¬ËüÒ²ÊÇÒ»¸öÈ«ÃæµÄºËËáÐòÁÐÊý¾Ý¿â¡£¸ÃÊý¾Ý¿âÓÉOracalÊý¾Ý¿âϵͳ¹ÜÀíά»¤£¬²éѯ¼ìË÷¿ÉÒÔͨ¹ýͨ¹ýÒòÌØÍøÉϵÄÐòÁÐÌáȡϵͳ(SRS)·þÎñÍê³É¡£ÏòEMBLºËËáÐòÁÐÊý¾Ý¿âÌá½»ÐòÁпÉÒÔͨ¹ý»ùÓÚWebµÄWEBIN¹¤¾ß£¬Ò²¿ÉÒÔÓÃSequinÈí¼þÀ´Íê³É¡£ Êý¾Ý¿âÍøÖ·ÊÇ£º£ºhttp://www.ebi.ac.uk/embl/¡£ SRSµÄÍøÖ·ÊÇ£º£ºhttp://srs.ebi.ac.uk/¡£ WEBINµÄÍøÖ·ÊÇ£º£ºhttp://www.ebi.ac.uk/embl/Submission/webin.html¡£ 3. DDBJÊý¾Ý¿â ÈÕ±¾DNAÊý¾Ý²Ö¿â(DDBJ)Ò²ÊÇÒ»¸öÈ«ÃæµÄºËËáÐòÁÐÊý¾Ý¿â£¬ÓëGenbankºÍEMBLºËËá¿âºÏ×÷½»»»Êý¾Ý¡£¿ÉÒÔʹÓÃÆäÖ÷Ò³ÉÏÌṩµÄSRS¹¤¾ß½øÐÐÊý¾Ý¼ìË÷ºÍÐòÁзÖÎö¡£¿ÉÒÔÓÃSequinÈí¼þÏò¸ÃÊý¾Ý¿âÌá½»ÐòÁС£ DDBJµÄÍøÖ·ÊÇ£º£ºhttp://www.ddbj.nig.ac.jp/¡£ 4. GDB »ùÒò×éÊý¾Ý¿â(GDΪÈËÀà»ùÒò×鼯»®(HGP)±£´æºÍ´¦Àí»ùÒò×éͼÆ×Êý¾Ý¡£GDBµÄÄ¿±êÊǹ¹½¨¹ØÓÚÈËÀà»ùÒò×éµÄ°Ù¿ÆÈ«Ê飬³ýÁ˹¹½¨»ùÒò×éͼÆ×Ö®Í⣬»¹¿ª·¢ÁËÃèÊöÐòÁÐˮƽµÄ»ùÒò×éÄÚÈݵķ½·¨£¬°üÀ¨ÐòÁбäÒìºÍÆäËü¶Ô¹¦ÄܺͱíÐ͵ÄÃèÊö¡£Ä¿Ç°GDBÖÐÓУºÈËÀà»ùÒò×éÇøÓò(°üÀ¨»ùÒò¡¢¿Ë¡¡¢amplimers PCR ±ê¼Ç¡¢¶Ïµãbreakpoints¡¢Ï¸°ûÒÅ´«±ê¼Çcytogenetic markers¡¢Ò×Ëéλµãfragile sites¡¢ESTÐòÁС¢×ÛºÏÇøÓòsyndromic regions¡¢contigsºÍÖØ¸´ÐòÁÐ)£»ÈËÀà»ùÒò×éͼÆ×(°üÀ¨Ï¸°ûÒÅ´«Í¼Æ×¡¢Á¬½ÓͼÆ×¡¢·ÅÉäÐÔÔÓ½»Í¼Æ×¡¢content contigͼÆ×ºÍ×ÛºÏͼÆ×µÈ)£»ÈËÀà»ùÒò×éÄڵıäÒì(°üÀ¨Í»±äºÍ¶à̬ÐÔ£¬¼ÓÉϵÈλ»ùÒòƵÂÊÊý¾Ý)¡£GDBÊý¾Ý¿âÒÔ¶ÔÏóÄ£ÐÍÀ´±£´æÊý¾Ý£¬Ìṩ»ùÓÚWebµÄÊý¾Ý¶ÔÏó¼ìË÷·þÎñ£¬Óû§¿ÉÒÔËÑË÷¸÷ÖÖÀàÐ͵ĶÔÏ󣬲¢ÒÔͼÐη½Ê½¹Û¿´»ùÒò×éͼÆ×¡£ GDBµÄÍøÖ·ÊÇ£º£ºhttp://www.gdb.org/¡£ GDBµÄ¹úÄÚ¾µÏñÊÇ£º£ºhttp://gdb.pku.edu.cn/gdb/¡£ 2.2 µ°°×ÖÊÊý¾Ý¿â 1. PIRºÍPSD PIR¹ú¼Êµ°°×ÖÊÐòÁÐÊý¾Ý¿â(PSD)ÊÇÓɵ°°×ÖÊÐÅÏ¢×ÊÔ´(PIR)¡¢Ä½ÄáºÚµ°°×ÖÊÐòÁÐÐÅÏ¢ÖÐÐÄ(MIPS)ºÍÈÕ±¾¹ú¼Êµ°°×ÖÊÐòÁÐÊý¾Ý¿â(JIPID)¹²Í¬Î¬»¤µÄ¹ú¼ÊÉÏ×î´óµÄ¹«¹²µ°°×ÖÊÐòÁÐÊý¾Ý¿â¡£ÕâÊÇÒ»¸öÈ«ÃæµÄ¡¢¾¹ý×¢Ê͵ġ¢·ÇÈßÓàµÄµ°°×ÖÊÐòÁÐÊý¾Ý¿â£¬°üº¬³¬¹ý142,000Ìõµ°°×ÖÊÐòÁÐ(ÖÁ99Äê9ÔÂ)£¬ÆäÖаüÀ¨À´×Ô¼¸Ê®¸öÍêÕû»ùÒò×éµÄµ°°×ÖÊÐòÁС£ËùÓÐÐòÁÐÊý¾Ý¶¼¾¹ýÕûÀí£¬³¬¹ý99%µÄÐòÁÐÒѰ´µ°°×ÖʼÒ×å·ÖÀ࣬һ°ëÒÔÉÏ»¹°´µ°°×Öʳ¬¼Ò×å½øÐÐÁË·ÖÀà¡£PSDµÄ×¢ÊÍÖл¹°üÀ¨¶ÔÐí¶àÐòÁС¢½á¹¹¡¢»ùÒò×éºÍÎÄÏ×Êý¾Ý¿âµÄ½»²æË÷Òý£¬ÒÔ¼°Êý¾Ý¿âÄÚ²¿ÌõĿ֮¼äµÄË÷Òý£¬ÕâЩÄÚ²¿Ë÷Òý°ïÖúÓû§ÔÚ°üÀ¨¸´ºÏÎø£µ×ÎïÏ໥×÷ÓᢻºÍµ÷¿Ø¼¶ÁªºÍ¾ßÓй²Í¬ÌØÕ÷µÄÌõĿ֮¼ä·½±ãµÄ¼ìË÷¡£Ã¿¼¾¶È¶¼·¢ÐÐÒ»´ÎÍêÕûµÄÊý¾Ý¿â£¬Ã¿ÖÜ¿ÉÒԵõ½¸üв¿·Ö¡£ PSDÊý¾Ý¿âÓм¸¸ö¸¨ÖúÊý¾Ý¿â£¬Èç»ùÓÚ³¬¼Ò×åµÄ·ÇÈßÓà¿âµÈ¡£PIRÌṩÈýÀàÐòÁÐËÑË÷·þÎñ£º»ùÓÚÎı¾µÄ½»»¥Ê½¼ìË÷£»±ê×¼µÄÐòÁÐÏàËÆÐÔËÑË÷£¬°üÀ¨BLAST¡¢FASTAµÈ£»½áºÏÐòÁÐÏàËÆÐÔ¡¢×¢ÊÍÐÅÏ¢ºÍµ°°×ÖʼÒ×åÐÅÏ¢µÄ¸ß¼¶ËÑË÷£¬°üÀ¨°´×¢ÊÍ·ÖÀàµÄÏàËÆÐÔËÑË÷¡¢½á¹¹ÓòËÑË÷GeneFINDµÈ¡£ PIRºÍPSDµÄÍøÖ·ÊÇ£º£ºhttp://pir.georgetown.edu/¡£ Êý¾Ý¿âÏÂÔØµØÖ·ÊÇ£º£ºftp://nbrfa.georgetown.edu/pir/¡£ 2. SWISS-PROT SWISS-PROTÊǾ¹ý×¢Ê͵ĵ°°×ÖÊÐòÁÐÊý¾Ý¿â£¬ÓÉÅ·ÖÞÉúÎïÐÅϢѧÑо¿Ëù(EBI)ά»¤¡£Êý¾Ý¿âÓɵ°°×ÖÊÐòÁÐÌõÄ¿¹¹³É£¬Ã¿¸öÌõÄ¿°üº¬µ°°×ÖÊÐòÁС¢ÒýÓÃÎÄÏ×ÐÅÏ¢¡¢·ÖÀàѧÐÅÏ¢¡¢×¢Ê͵ȣ¬×¢ÊÍÖаüÀ¨µ°°×ÖʵŦÄÜ¡¢×ªÂ¼ºóÐÞÊΡ¢ÌØÊâλµãºÍÇøÓò¡¢¶þ¼¶½á¹¹¡¢Ëļ¶½á¹¹¡¢ÓëÆäËüÐòÁеÄÏàËÆÐÔ¡¢ÐòÁвÐȱÓë¼²²¡µÄ¹ØÏµ¡¢ÐòÁбäÒìÌåºÍ³åÍ»µÈÐÅÏ¢¡£SWISS-PROTÖо¡¿ÉÄܼõÉÙÁËÈßÓàÐòÁУ¬²¢ÓëÆäËü30¶à¸öÊý¾Ý½¨Á¢Á˽»²æÒýÓã¬ÆäÖаüÀ¨ºËËáÐòÁп⡢µ°°×ÖÊÐòÁпâºÍµ°°×Öʽṹ¿âµÈ¡£ ÀûÓÃÐòÁÐÌáȡϵͳ(SRS)¿ÉÒÔ·½±ãµØ¼ìË÷SWISS-PROTºÍÆäËüEBIµÄÊý¾Ý¿â¡£ SWISS-PROTÖ»½ÓÊÜÖ±½Ó²âÐò»ñµÃµÄµ°°×ÖÊÐòÁУ¬ÐòÁÐÌá½»¿ÉÒÔÔÚÆäWebÒ³ÃæÉÏÍê³É¡£ SWISS-PROTµÄÍøÖ·ÊÇ£º£ºhttp://www.ebi.ac.uk/swissprot/¡£ 3. PROSITE PROSITEÊý¾Ý¿âÊÕ¼¯ÁËÉúÎïѧÓÐÏÔÖøÒâÒåµÄµ°°×ÖÊλµãºÍÐòÁÐģʽ£¬²¢Äܸù¾ÝÕâЩλµãºÍģʽ¿ìËٺͿɿ¿µØ¼ø±ðÒ»¸öδ֪¹¦Äܵĵ°°×ÖÊÐòÁÐÓ¦¸ÃÊôÓÚÄÄÒ»¸öµ°°×ÖʼÒ×å¡£ÓеÄÇé¿öÏ£¬Ä³¸öµ°°×ÖÊÓëÒÑÖª¹¦Äܵ°°×ÖʵÄÕûÌåÐòÁÐÏàËÆÐԺܵͣ¬µ«ÓÉÓÚ¹¦ÄܵÄÐèÒª±£ÁôÁËÓ빦ÄÜÃÜÇÐÏà¹ØµÄÐòÁÐģʽ£¬ÕâÑù¾Í¿ÉÄÜͨ¹ýPROSITEµÄËÑË÷ÕÒµ½Òþº¬µÄ¹¦ÄÜmotif£¬Òò´ËÊÇÐòÁзÖÎöµÄÓÐЧ¹¤¾ß¡£PROSITEÖÐÉæ¼°µÄÐòÁÐģʽ°üÀ¨Ã¸µÄ´ß»¯Î»µã¡¢ÅäÌå½áºÏλµã¡¢Óë½ðÊôÀë×Ó½áºÏµÄ²Ð»ù¡¢¶þÁò¼üµÄ°ëë×°±Ëá¡¢ÓëС·Ö×Ó»òÆäËüµ°°×ÖʽáºÏµÄÇøÓòµÈ£»³ýÁËÐòÁÐģʽ֮Í⣬PROSITE»¹°üÀ¨ÓɶàÐòÁбȶԹ¹½¨µÄprofile£¬ÄܸüÃô¸ÐµØ·¢ÏÖÐòÁÐÓëprofileµÄÏàËÆÐÔ¡£PROSITEµÄÖ÷Ò³ÉÏÌṩ¸÷ÖÖÏà¹Ø¼ìË÷·þÎñ¡£ PROSITEµÄÍøÖ·ÊÇ£º£ºhttp://www.expasy.ch/prosite/¡£ 4. PDB µ°°×ÖÊÊý¾Ý²Ö¿â(PDÊǹú¼ÊÉÏΨһµÄÉúÎï´ó·Ö×ӽṹÊý¾Ýµµ°¸¿â£¬ÓÉÃÀ¹úBrookhaven¹ú¼ÒʵÑéÊÒ½¨Á¢¡£PDBÊÕ¼¯µÄÊý¾ÝÀ´Ô´ÓÚX¹â¾§ÌåÑÜÉäºÍºË´Å¹²Õñ(NMR)µÄÊý¾Ý£¬¾¹ýÕûÀíºÍÈ·ÈÏºó´æµµ¶ø³É¡£Ä¿Ç°PDBÊý¾Ý¿âµÄά»¤ÓɽṹÉúÎïÐÅϢѧÑо¿ºÏ×÷×éÖ¯(RCS¸ºÔð¡£RCSBµÄÖ÷·þÎñÆ÷ºÍÊÀ½ç¸÷µØµÄ¾µÏñ·þÎñÆ÷ÌṩÊý¾Ý¿âµÄ¼ìË÷ºÍÏÂÔØ·þÎñ£¬ÒÔ¼°¹ØÓÚPDBÊý¾ÝÎļþ¸ñʽºÍÆäËüÎĵµµÄ˵Ã÷£¬PDBÊý¾Ý»¹¿ÉÒÔ´Ó·¢ÐеĹâÅÌ»ñµÃ¡£Ê¹ÓÃRasmolµÈÈí¼þ¿ÉÒÔÔÚ¼ÆËã»úÉϰ´PDBÎļþÏÔʾÉúÎï´ó·Ö×ÓµÄÈýά½á¹¹¡£ RCSBµÄPDBÊý¾Ý¿âÍøÖ·ÊÇ£º£ºhttp://www.rcsb.org/pdb/¡£ 5. SCOP µ°°×Öʽṹ·ÖÀà(SCOP)Êý¾Ý¿âÏêϸÃèÊöÁËÒÑÖªµÄµ°°×Öʽṹ֮¼äµÄ¹ØÏµ¡£·ÖÀà»ùÓÚÈô¸É²ã´Î£º¼Ò×壬ÃèÊöÏà½üµÄ½ø»¯¹ØÏµ£»³¬¼Ò×壬ÃèÊöÔ¶Ô´µÄ½ø»¯¹ØÏµ£»ÕÛµþ×Ó(fold)£¬ÃèÊö¿Õ¼ä¼¸ºÎ½á¹¹µÄ¹ØÏµ£»ÕÛµþÀ࣬ËùÓÐÕÛµþ×Ó±»¹éÓÚÈ«¦Á¡¢È«¦Â¡¢¦Á/¦Â¡¢¦Á£«¦ÂºÍ¶à½á¹¹ÓòµÈ¼¸¸ö´óÀà¡£SCOP»¹Ìṩһ¸ö·ÇÈßÓàµÄASTRAILÐòÁп⣬Õâ¸ö¿âͨ³£±»ÓÃÀ´ÆÀ¹À¸÷ÖÖÐòÁбȶÔËã·¨¡£´ËÍ⣬SCOP»¹Ìṩһ¸öPDB-ISLÖнéÐòÁп⣬ͨ¹ýÓëÕâ¸ö¿âÖÐÐòÁеÄÁ½Á½±È¶Ô£¬¿ÉÒÔÕÒµ½Óëδ֪½á¹¹ÐòÁÐÔ¶ÔµµÄÒÑÖª½á¹¹ÐòÁС£ SCOPµÄÍøÖ·ÊÇ£º£ºhttp://scop.mrc-lmb.cam.ac.uk/scop/¡£ 6. COG µ°°×ÖÊֱϵͬԴ´Ø(COGs)Êý¾Ý¿âÊǶÔϸ¾ú¡¢ÔåÀàºÍÕæºËÉúÎïµÄ21¸öÍêÕû»ùÒò×éµÄ±àÂëµ°°×£¬¸ù¾Ýϵͳ½ø»¯¹ØÏµ·ÖÀ๹½¨¶ø³É¡£COG¿â¶ÔÓÚÔ¤²âµ¥¸öµ°°×ÖʵŦÄܺÍÕû¸öлùÒò×éÖе°°×ÖʵŦÄܶ¼ºÜÓÐÓá£ÀûÓÃCOGNITOR³ÌÐò£¬¿ÉÒÔ°Ñij¸öµ°°×ÖÊÓëËùÓÐCOGsÖеĵ°°×ÖʽøÐбȶԣ¬²¢°ÑËü¹éÈëÊʵ±µÄCOG´Ø¡£COG¿âÌṩÁ˶ÔCOG·ÖÀàÊý¾ÝµÄ¼ìË÷ºÍ²éѯ£¬»ùÓÚWebµÄCOGNITOR·þÎñ£¬ÏµÍ³½ø»¯Ä£Ê½µÄ²éѯ·þÎñµÈ¡£ COG¿âµÄÍøÖ·ÊÇ£º£ºhttp://www.ncbi.nlm.nih.gov/COG¡£ ÏÂÔØCOG¿âºÍCOGNITOR³ÌÐòÔÚ£º£ºftp://ncbi.nlm.nih.gov/pub/COG¡£ 2.3 ¹¦ÄÜÊý¾Ý¿â 1. KEGG ¾©¶¼»ùÒòºÍ»ùÒò×é°Ù¿ÆÈ«Êé(KEGG)ÊÇϵͳ·ÖÎö»ùÒò¹¦ÄÜ£¬ÁªÏµ»ùÒò×éÐÅÏ¢ºÍ¹¦ÄÜÐÅÏ¢µÄ֪ʶ¿â¡£»ùÒò×éÐÅÏ¢´æ´¢ÔÚGENESÊý¾Ý¿âÀ°üÀ¨ÍêÕûºÍ²¿·Ö²âÐòµÄ»ùÒò×éÐòÁУ»¸ü¸ß¼¶µÄ¹¦ÄÜÐÅÏ¢´æ´¢ÔÚPATHWAYÊý¾Ý¿âÀ°üÀ¨Í¼½âµÄϸ°ûÉú»¯¹ý³ÌÈç´úл¡¢Ä¤×ªÔË¡¢ÐźŴ«µÝ¡¢Ï¸°ûÖÜÆÚ£¬»¹°üÀ¨Í¬Ïµ±£ÊصÄ×Óͨ·µÈÐÅÏ¢£»KEGGµÄÁíÒ»¸öÊý¾Ý¿âÊÇLIGAND£¬°üº¬¹ØÓÚ»¯Ñ§ÎïÖÊ¡¢Ã¸·Ö×Ó¡¢Ã¸·´Ó¦µÈÐÅÏ¢¡£KEGGÌṩÁËJavaµÄͼÐι¤¾ßÀ´·ÃÎÊ»ùÒò×éͼÆ×£¬±È½Ï»ùÒò×éͼÆ×ºÍ²Ù×÷±í´ïͼÆ×£¬ÒÔ¼°ÆäËüÐòÁбȽϡ¢Í¼ÐαȽϺÍͨ·¼ÆËãµÄ¹¤¾ß£¬¿ÉÒÔÃâ·Ñ»ñÈ¡¡£ KEGGµÄÍøÖ·ÊÇ£º£ºhttp://www.genome.ad.jp/kegg/¡£ 2. DIP Ï໥×÷Óõĵ°°×ÖÊÊý¾Ý¿â(DIP)ÊÕ¼¯ÁËÓÉʵÑéÑéÖ¤µÄµ°°×ÖÊ£µ°°×ÖÊÏ໥×÷Óá£Êý¾Ý¿â°üÀ¨µ°°×ÖʵÄÐÅÏ¢¡¢Ï໥×÷ÓõÄÐÅÏ¢ºÍ¼ì²âÏ໥×÷ÓõÄʵÑé¼¼ÊõÈý¸ö²¿·Ö¡£Óû§¿ÉÒÔ¸ù¾Ýµ°°×ÖÊ¡¢ÉúÎïÎïÖÖ¡¢µ°°×Öʳ¬¼Ò×å¡¢¹Ø¼ü´Ê¡¢ÊµÑé¼¼Êõ»òÒýÓÃÎÄÏ×À´²éѯDIPÊý¾Ý¿â¡£ DIPµÄÍøÖ·ÊÇ£º£ºhttp://dip.doe-mbi.ucla.edu/¡£ 3. ASDB ¿É±ä¼ô½ÓÊý¾Ý¿â(ASD°üÀ¨µ°°×ÖÊ¿âºÍºËËá¿âÁ½²¿·Ö¡£ASDB(µ°°×ÖÊ)²¿·ÖÀ´Ô´ÓÚSWISS-PROTµ°°×ÖÊÐòÁп⣬ͨ¹ýѡȡÓпɱä¼ô½Ó×¢Ê͵ÄÐòÁУ¬ËÑË÷Ïà¹Ø¿É±ä¼ô½ÓµÄÐòÁУ¬¾¹ýÐòÁбȶԡ¢É¸Ñ¡ºÍ·ÖÀ๹½¨¶ø³É¡£ASDB(ºËËá)²¿·ÖÀ´×ÔGenbankÖÐÌá¼°ºÍ×¢Ê͵Ŀɱä¼ô½ÓµÄÍêÕû»ùÒò¹¹³É¡£Êý¾Ý¿âÌṩÁË·½±ãµÄËÑË÷·þÎñ¡£ ASDBµÄÍøÖ·ÊÇ£º£ºhttp://cbcg.nersc.gov/asdb¡£ 4. TRRD ת¼µ÷¿ØÇøÊý¾Ý¿â(TRRD)ÊÇÔÚ²»¶Ï»ýÀÛµÄÕæºËÉúÎï»ùÒòµ÷¿ØÇø½á¹¹£¹¦ÄÜÌØÐÔÐÅÏ¢»ù´¡ÉϹ¹½¨µÄ¡£Ã¿Ò»¸öTRRDµÄÌõÄ¿Àï°üº¬Ìض¨»ùÒò¸÷Öֽṹ£¹¦ÄÜÌØÐÔ£º×ªÂ¼Òò×Ó½áºÏλµã¡¢Æô¶¯×Ó¡¢ÔöÇ¿×Ó¡¢¾²Ä¬×Ó¡¢ÒÔ¼°»ùÒò±í´ïµ÷¿ØÄ£Ê½µÈ¡£TRRD°üÀ¨Îå¸öÏà¹ØµÄÊý¾Ý±í£ºTRRDGENES(°üº¬ËùÓÐTRRD¿â»ùÒòµÄ»ù±¾ÐÅÏ¢ºÍµ÷¿Øµ¥ÔªÐÅÏ¢)£»TRRDSITES(°üÀ¨µ÷¿ØÒò×Ó½áºÏλµãµÄ¾ßÌåÐÅÏ¢)£»TRRDFACTORS(°üÀ¨TRRDÖÐÓë¸÷¸öλµã½áºÏµÄµ÷¿ØÒò×ӵľßÌåÐÅÏ¢)£»TRRDEXP(°üÀ¨¶Ô»ùÒò±í´ïģʽµÄ¾ßÌåÃèÊö)£»TRRDBIB(°üÀ¨ËùÓÐ×¢ÊÍÉæ¼°µÄ²Î¿¼ÎÄÏ×)¡£TRRDÖ÷Ò³ÌṩÁ˶ÔÕ⼸¸öÊý¾Ý±íµÄ¼ìË÷·þÎñ¡£ TRRDµÄÍøÖ·ÊÇ£º£ºhttp://wwwmgs.bionet.nsc.ru/mgs/dbases/trrd4/¡£ 5. TRANSFAC TRANSFACÊý¾Ý¿âÊǹØÓÚת¼Òò×Ó¡¢ËüÃÇÔÚ»ùÒò×éÉϵĽáºÏλµãºÍÓëDNA½áºÏµÄprofilesµÄÊý¾Ý¿â¡£ÓÉSITE¡¢GENE¡¢FACTOR¡¢CLASS¡¢MATRIX¡¢CELLS¡¢METHODºÍREFERENCEµÈÊý¾Ý±í¹¹³É¡£´ËÍ⣬»¹Óм¸¸öÓëTRANSFACÃÜÇÐÏà¹ØµÄÀ©Õ¹¿â£ºPATHODB¿âÊÕ¼¯ÁË¿ÉÄܵ¼Ö²¡Ì¬µÄÍ»±äµÄת¼Òò×ӺͽáºÏλµã£»S/MART DBÊÕ¼¯ÁËÓëȾɫÌå½á¹¹±ä»¯Ïà¹ØµÄµ°°×Òò×ÓºÍλµãµÄÐÅÏ¢£»TRANSPATH¿âÓÃÓÚÃèÊöÓëת¼Òò×Óµ÷¿ØÏà¹ØµÄÐźŴ«µÝµÄÍøÂ磻CYTOMER¿â±íÏÖÁËÈËÀàת¼Òò×ÓÔÚ¸÷¸öÆ÷¹Ù¡¢Ï¸°ûÀàÐÍ¡¢ÉúÀíϵͳºÍ·¢ÓýʱÆÚµÄ±í´ï×´¿ö¡£TRANSFAC¼°ÆäÏà¹ØÊý¾Ý¿â¿ÉÒÔÃâ·ÑÏÂÔØ£¬Ò²¿ÉÒÔͨ¹ýWeb½øÐмìË÷ºÍ²éѯ¡£ TRANSFACµÄÍøÖ·ÊÇ£º£ºhttp://transfac.gbf.de/TRANSFAC/¡£ 2.4 ÆäËüÊý¾Ý¿â×ÊÔ´ 1. DBCat DBCatÊÇÉúÎïÐÅÏ¢Êý¾Ý¿âµÄĿ¼Êý¾Ý¿â£¬ËüÊÕ¼¯ÁË500¶à¸öÉúÎïÐÅϢѧÊý¾Ý¿âµÄÐÅÏ¢£¬²¢¸ù¾ÝËüÃǵÄÓ¦ÓÃÁìÓò½øÐÐÁË·ÖÀà¡£°üÀ¨DNA¡¢RNA¡¢µ°°×ÖÊ¡¢»ùÒò×顢ͼÆ×¡¢µ°°×Öʽṹ¡¢ÎÄÏ×Öø×÷µÈ»ù±¾ÀàÐÍ¡£Êý¾Ý¿â¿ÉÒÔÃâ·ÑÏÂÔØ»òÔÚÍøÂçÉϼìË÷²éѯ¡£ DBCatµÄÍøÖ·ÊÇ£º£ºhttp://www.infobiogen.fr/services/dbcat/¡£ ÏÂÔØDBCatÔÚ£º£ºftp://ftp.infobiogen.fr/pub/db/dbcat¡£ 2. PubMed PubMedÊÇNCBIά»¤µÄÎÄÏ×ÒýÓÃÊý¾Ý¿â£¬Ìṩ¶ÔMEDLINE¡¢Pre-MEDLINEµÈÎÄÏ×Êý¾Ý¿âµÄÒýÓòéѯºÍ¶Ô´óÁ¿ÍøÂç¿ÆÑ§Ààµç×ÓÆÚ¿¯µÄÁ´½Ó¡£ÀûÓÃEntrezϵͳ¿ÉÒÔ¶ÔPubMed½øÐз½±ãµÄ²éѯ¼ìË÷¡£ PubMedµÄÍøÖ·ÊÇ£º£ºhttp://www.ncbi.nlm.nih.gov/¡£ ³ýÁËÒÔÉÏÌá¼°µÄÊý¾ÝÖ®Í⣬»¹ÓÐÐíÐí¶à¶àµÄרÃÅÉúÎïÐÅÏ¢Êý¾Ý¿â£¬Éæ¼°ÁËĿǰÉúÎïѧÑо¿µÄ¸÷¸ö²ãÃæºÍÁìÓò£¬ÓÉÓÚÆª·ùËùÏÞÎÞ·¨Ò»Ò»ÏêÊö¡£¹úÄÚÒ²ÓÐһЩ´óÊý¾Ý¿âµÄ¾µÏñÕ¾µãºÍ×Ô¼º¿ª·¢µÄÓÐÌØÉ«µÄÊý¾Ý¿â£¬ÈçÅ·ÖÞ·Ö×ÓÉúÎïÑ§ÍøÂç×éÖ¯EMBNetÖйú½Úµã±±¾©´óѧ·Ö×ÓÉúÎïÐÅÏ¢¾µÏñϵͳ£¬ÉϺ£²©ÈÝ»ùÒò¹«Ë¾ÓëÉϺ£¼ÎÈðÈí¼þ¹«Ë¾ºÏ×÷¿ª·¢µÄ¹ú²úºº»¯»ùÒòÊý¾Ý¿â¼°·ÖÎö¹ÜÀíϵͳ£¬Í¬Ê±¹ú¼Ò¼¶µÄÉúÎïÐÅϢѧÖÐÐÄÒ²Ôڳィ֮ÖС£ÎÒÃÇÆÚ´ý¹úÄÚÄÜÓиü¶à¸ßÖÊÁ¿ºÍʹÓñãÀûµÄÊý¾Ý¿â×ÊÔ´£¬Íƶ¯ÎÒ¹úÉúÎïÐÅϢѧºÍÕû¸öÉúÃü¿ÆÑ§µÄ·¢Õ¹¡£ Ç廪´óѧÉúÎïÐÅϢѧÑо¿ËùÍøÖ·£º£ºhttp://bioinfo.tsinghua.edu.cn/ ±±¾©´óѧÉúÎïÐÅÏ¢¾µÏñÏµÍ³ÍøÖ·£º£ºhttp://cbi.pku.edu.cn/ |
4Â¥2009-04-26 00:37:47
ÏãÁâ¶ù
Ìú¸Ëľ³æ (ÖøÃûдÊÖ)
- BioEPI: 1
- Ó¦Öú: 14 (СѧÉú)
- ½ð±Ò: 7591
- Ìû×Ó: 2220
- ÔÚÏß: 198Сʱ
- ³æºÅ: 420152
5Â¥2009-04-26 08:49:47
7Â¥2009-04-27 00:28:45
8Â¥2009-04-27 00:54:34
10Â¥2009-04-27 06:59:56
13Â¥2009-04-27 08:26:05
14Â¥2009-04-27 09:08:18
15Â¥2009-04-27 09:52:05
17Â¥2009-04-27 14:30:02
18Â¥2009-04-27 18:02:16
19Â¥2009-04-27 20:54:20
21Â¥2009-04-29 11:01:26
22Â¥2009-04-29 20:11:02
23Â¥2009-06-19 02:58:37
HarveyWang
¾èÖú¹ó±ö (ÖªÃû×÷¼Ò)
- BioEPI: 14
- Ó¦Öú: 80 (³õÖÐÉú)
- ½ð±Ò: 2277.2
- Ìû×Ó: 6880
- ÔÚÏß: 946Сʱ
- ³æºÅ: 528557
24Â¥2009-06-19 08:36:11
wlt728
Ìú¸Ëľ³æ (ÖøÃûдÊÖ)
- BioEPI: 1
- Ó¦Öú: 38 (СѧÉú)
- ½ð±Ò: 13652.1
- Ìû×Ó: 2130
- ÔÚÏß: 344.5Сʱ
- ³æºÅ: 275024
25Â¥2009-07-06 07:42:00
ѩɽ·Éºü7233
Ìú¸Ëľ³æ (ÖøÃûдÊÖ)
- BioEPI: 9
- Ó¦Öú: 10 (Ó×¶ùÔ°)
- ½ð±Ò: 18695.9
- Ìû×Ó: 1534
- ÔÚÏß: 199.6Сʱ
- ³æºÅ: 593313
26Â¥2009-07-06 09:49:30
27Â¥2009-07-29 15:18:30
28Â¥2009-09-03 13:57:01
29Â¥2009-09-03 20:53:03
luhaitao84
ÖÁ×ðľ³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 7 (Ó×¶ùÔ°)
- ¹ó±ö: 1.412
- ½ð±Ò: 10417.6
- Ìû×Ó: 1698
- ÔÚÏß: 75.3Сʱ
- ³æºÅ: 580938
30Â¥2009-09-04 00:05:37
¼òµ¥»Ø¸´
6956Â¥
2009-04-26 19:44
»Ø¸´

fubsd9Â¥
2009-04-27 02:48
»Ø¸´

langzu711Â¥
2009-04-27 07:32
»Ø¸´
лл·ÖÏí£¡
yufuxian12Â¥
2009-04-27 08:24
»Ø¸´
¶¥£¡£¡£¡£¡£¡£¡£¡£¡£¡
ycl31516Â¥
2009-04-27 11:31
»Ø¸´



Shumman20Â¥
2009-04-28 18:33
»Ø¸´
¶¥£¡£¡£¡













»Ø¸´´ËÂ¥
